Capital Insight Partners, LLC Merck & Co., Inc. Transaction History

Capital Insight Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$123.8 - $132.96 $21,665 - $23,268	-175 Reduced 8.15%	1,972 $244,000
Q1 2024 Apr 16, 2024	SELL	$113.24 - $131.95 $1,019 - $1,187	-9 Reduced 0.42%	2,147 $283,000
Q4 2023 Jan 24, 2024	SELL	$100.18 - $109.02 $4,708 - $5,123	-47 Reduced 2.13%	2,156 $235,000
Q3 2023 Oct 30, 2023	SELL	$102.95 - $114.33 $9,780 - $10,861	-95 Reduced 4.13%	2,203 $226,000
Q2 2023 Jul 21, 2023	SELL	$108.61 - $118.38 $26,283 - $28,647	-242 Reduced 9.53%	2,298 $265,000
Q1 2023 Apr 27, 2023	BUY	$102.94 - $114.86 $29,234 - $32,620	284 Added 12.59%	2,540 $270,000
Q4 2022 Feb 07, 2023	BUY	$87.44 - $112.11 $197,264 - $252,920	2,256 New	2,256 $250,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Capital Insight Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Insight Partners, LLC with notifications on news.